S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Genetic Technologies Announces Financial Results for Quarter Ended March 31, 2013 (2013/4/30)|
|Genetic Technologies Announces Financial Results for Half-Year Ended 31 December 2012 (2013/2/22)|
|Genetic Technologies Executes Agreement With Nationwide Provider Network (2013/5/3)|
|Genetic Technologies Provides U.S. Patent Re-Examination Update (2013/3/15)|
|Synageva BioPharma™ Joins NORD, EURORDIS, and The Global Genes Project in Support of Rare Disease Day 2013 (2013/2/28)|
|The Centers for Women's Health in Stamford CT Pioneers Breast Cancer Risk Assessment (2013/3/18)|
|ICM's New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland (2013/4/4)|
|22nd Century Group Announces U.S. Patent Issues for MPO Nicotine Biosynthesis Gene (2013/4/3)|
|Meridian Bioscience Announces illumigene® Group A Streptococcus and illumigene® Group B Streptococcus Tests Categorized “Moderate Complexity” by FDA (2013/3/18)|
|Life Technologies Announces SFDA Clearance for its 3500xL Dx Genetic Analyzer in China and the Launch of 10 Assays from its Joint Venture with Daan Gene (2013/3/27)|
Click above to view more mutual fund data and stats for gene - Genetic Technologies Limited ADR.